Targeted Treatment of Esophagogastric Cancer

Publisher： Karger

E-ISSN： 2296-5262|39|12|788-794

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.12, 2016-11, pp. : 788-794

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel targeted agents for the treatment of lung cancer in China

By  

CANCER, Vol. 121, Iss. S17, 2015-09 ,pp. : 3089-3096

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 122-131

Karger

Access to resources Recommend Favorite

Targeted HER2 Treatment in Advanced Gastric Cancer

By  

Oncology, Vol. 78, Iss. 1, 2010-02 ,pp. : 26-33

Karger

Access to resources Recommend Favorite

Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 1350-1925, Iss. 10, 2015-10 ,pp. : 1495-1503

John Wiley & Sons Inc

Access to resources Recommend Favorite

Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 10, 2015-10 ,pp. : 1495-1503

John Wiley & Sons Inc

Access to resources Recommend Favorite